We are pleased to announce that the ACTA Annual Scientific Meeting will be held from 7-8 November 2022. The theme for the two days will be - Implementing Evidence into Practice: how do we plan, engage and act to ensure our trials have the greatest impact and change practice.
Implementation trials seek to determine the most effective way of translating knowledge into practice.
The meeting will include talks from regulators and government to hear how trialists, regulators and government can all work together to ensure quality evidence is generated and the translation into practice is fast and complete.
After two years of online meetings, we look forward to holding this event in person at SAHMRI in Adelaide. We have a limited number of spaces available for this event - so we encourage you to get in early once tickets sales go live in July.
Various sponsorship opportunities available. Please get in touch with Lea Hauchard, Events and Sponsorship Coordinator [email protected] for your prospectus.
Latest Resources
-
-
Nurse- and midwife-led trials in Australia and New Zealand: Scoping review protocol
-
Development of the Consumer Involvement and Engagement Toolkit
-
Strengthening the capacity, efficiency and effectiveness of Clinical Trials Networks: Activity Overview 2017–2021
-
ACTA 2020-2021 Annual Report
-
MEDIA RELEASE: ACTA appoints Prof Steve Webb as its new Chair and Ian Wilson as Additional Independent Director
-
Official Opening of the 2020 ACTA Summit: Minister’s Address
-
Statistical Analysis Plan (SAP)
-
ACTA Board Charter
-
ACTA Constitution
-
ACTA Trial of the Year Award 2020 guidelines and nomination forms
-
ACTA Year in Review: Financial Year 2018-2019
-
ACTA Resources Brochure
-
ACTA activity work plan 2019 – 2020
-
Report on the activities and achievements of clinical trials networks in Australia 2004 – 2014
-
What a trialist should know about implementation to practice
-
Submission to MRFF Consultation
-
Submission to Medical Research Future Fund Priority Consultation
-
Medical Research Future Fund – clinical trial funding set to deliver significant benefits to Australian patients and the economy
-
ACTA Advisory Council minutes July 2017
-
Economic evaluation of investigator-initiated clinical trials conducted by networks
-
Economic evaluation of investigator-initiated clinical trials conducted by networks – Appendix: Individual trial-level results
-
Open letter to the Hon Greg Hunt MP following announcement of MRFF funding for ACTA and clinical trials
-
How can registries drive better translation of real world data into better quality care?
-
How can clinical trials networks drive better translation of evidence into better quality care?
-
How can registries drive better translation of real world data into better quality care?
-
The Global Perspective: Measuring the impact of Australian-led trials & registries internationally
-
What we don’t know about the health and economic benefit of trials and registries in Australia
-
What we know about the health and economic benefit of trials and registries in Australia
-
ACTA Summit 2016 – Opening address
-
Health system benefits from improved performance
-
ACTA Submission to the NHMRC Public Consultation on revisions to sections 3 & 5 of the National Statement
-
ACTA Summit 2016 – Dr Neil Soderlund
-
Medical Research Future Fund set to put high quality evidence at the heart of healthcare – historic moment for all Australians
-
ACTA STInG Submission to the NHMRC Structural Review
-
ACTA Submission to the NHMRC Structural Review
Latest Events
-
Clinical Trials 2022: National Tribute and Awards
-
ACTA’s 2021 Annual General Meeting and Advisory Council Meeting
-
Clinical Trials 2021: National Tribute and Award Ceremony
-
Clinical Trials 2020: National Tribute and Award Ceremony
-
ACTA Summit and Clinical Trials 2020 National Tribute and Award Ceremony
-
Australasian Gastro-Intestinal Trials Group 22nd Annual Scientific Meeting
-
ACTA Annual General Meeting
-
ACTA Advisory Council
-
ACTA International Clinical Trials Conference 2 – 5 October 2019